Legislation Details

File #: 2024 ACT-233    Version: 1 Name:
Type: Action Item Status: Passed
File created: 11/6/2024 In control: Personnel & Finance Committee
Final action: 11/18/2024
Title: Request for Waiver of Bid - Emergency Management - 3 MG Nasal RiVive (Nasal Naloxone) (Remedy Alliance Inc)
Attachments: 1. 2024 ACT-233 Bid Waiver - EM - RiVive1

Title

Request for Waiver of Bid - Emergency Management - 3 MG Nasal RiVive (Nasal Naloxone) (Remedy Alliance Inc)